Urueña, Analía <br/><br/>
Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.  [electronic resource] 

 -  Vaccine  06 2016 
 - 3222 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2016.03.099  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Dengue<br/>Dengue Vaccines<br/>Dengue Virus--immunology<br/>Humans<br/>Risk<br/>Vaccination